Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela R Reagan

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
JBMR Plus|November 19, 2020
Targeting Bone Cells During Sexual Maturation Reveals Sexually Dimorphic Regulation of Endochondral OssificationHeather Fairfield, Samantha Costa, Victoria DeMambro, et al.
Bonekey Reports|October 30, 2016
Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocolsUshashi Dadwal, Carolyne Falank, Heather Fairfield, et al.
Skeletal Radiology|June 27, 2016
Abdominal adipose tissue in MGUS and multiple myelomaJoyce Veld, Elizabeth K O'Donnell, Michaela R Reagan, et al.
Haematologica|May 19, 2019
Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse modelAlessandro Natoni, Mariah L Farrell, Sophie Harris, et al.
Bone|January 26, 2018
Development of a 3D bone marrow adipose tissue modelHeather Fairfield, Carolyne Falank, Mariah Farrell, et al.
Plos One|June 4, 2021
TRPM8 modulates temperature regulation in a sex-dependent manner without affecting cold-induced bone lossAdriana Lelis Carvalho, Annika Treyball, Daniel J Brooks, et al.
Journal of Breast Cancer|October 24, 2012
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In SituMichaela R Reagan, F Philipp Seib, Douglas W McMillin, et al.
Cancer Immunology, Immunotherapy : CII|January 11, 2020
The CD38<sup>low</sup> natural killer cell line KHYG1 transiently expressing CD16<sup>F158V</sup> in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricideSubhashis Sarkar, Sachin K S Chauhan, John Daly, et al.
Blood Reviews|February 1, 2015
The cancer glycome: carbohydrates as mediators of metastasisSiobhan V Glavey, Daisy Huynh, Michaela R Reagan, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial DysfunctionConnor S Murphy, Victoria E DeMambro, Samaa Fadel, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
JBMR Plus|November 19, 2020
Targeting Bone Cells During Sexual Maturation Reveals Sexually Dimorphic Regulation of Endochondral OssificationHeather Fairfield, Samantha Costa, Victoria DeMambro, et al.
Bonekey Reports|October 30, 2016
Tissue-engineered 3D cancer-in-bone modeling: silk and PUR protocolsUshashi Dadwal, Carolyne Falank, Heather Fairfield, et al.
Skeletal Radiology|June 27, 2016
Abdominal adipose tissue in MGUS and multiple myelomaJoyce Veld, Elizabeth K O'Donnell, Michaela R Reagan, et al.
Haematologica|May 19, 2019
Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse modelAlessandro Natoni, Mariah L Farrell, Sophie Harris, et al.
Bone|January 26, 2018
Development of a 3D bone marrow adipose tissue modelHeather Fairfield, Carolyne Falank, Mariah Farrell, et al.
Plos One|June 4, 2021
TRPM8 modulates temperature regulation in a sex-dependent manner without affecting cold-induced bone lossAdriana Lelis Carvalho, Annika Treyball, Daniel J Brooks, et al.
Journal of Breast Cancer|October 24, 2012
Stem Cell Implants for Cancer Therapy: TRAIL-Expressing Mesenchymal Stem Cells Target Cancer Cells In SituMichaela R Reagan, F Philipp Seib, Douglas W McMillin, et al.
Cancer Immunology, Immunotherapy : CII|January 11, 2020
The CD38<sup>low</sup> natural killer cell line KHYG1 transiently expressing CD16<sup>F158V</sup> in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricideSubhashis Sarkar, Sachin K S Chauhan, John Daly, et al.
Blood Reviews|February 1, 2015
The cancer glycome: carbohydrates as mediators of metastasisSiobhan V Glavey, Daisy Huynh, Michaela R Reagan, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Inhibition of Acyl-CoA Synthetase Long Chain Isozymes Decreases Multiple Myeloma Cell Proliferation and Causes Mitochondrial DysfunctionConnor S Murphy, Victoria E DeMambro, Samaa Fadel, et al.
Pageof 8